VEA
Virtus ETF Advisers’s Alaunos Therapeutics TCRT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-131,413
| Closed | -$86K | – | 473 |
|
|
2022
Q1 | $86K | Sell |
131,413
-7,788
| -6% | -$5.1K | 0.04% | 328 |
|
|
2021
Q4 | $152K | Buy |
139,201
+67,141
| +93% | +$73.3K | 0.06% | 344 |
|
|
2021
Q3 | $131K | Sell |
72,060
-3,766
| -5% | -$6.85K | 0.06% | 363 |
|
|
2021
Q2 | $200K | Sell |
75,826
-21,353
| -22% | -$56.3K | 0.08% | 348 |
|
|
2021
Q1 | $350K | Buy |
97,179
+1,706
| +2% | +$6.14K | 0.15% | 208 |
|
|
2020
Q4 | $241K | Sell |
95,473
-3,635
| -4% | -$9.18K | 0.1% | 324 |
|
|
2020
Q3 | $250K | Sell |
99,108
-13,511
| -12% | -$34.1K | 0.13% | 263 |
|
|
2020
Q2 | $369K | Buy |
112,619
+39,689
| +54% | +$130K | 0.17% | 240 |
|
|
2020
Q1 | $179K | Sell |
72,930
-10,638
| -13% | -$26.1K | 0.07% | 282 |
|
|
2019
Q4 | $394K | Buy |
83,568
+35,164
| +73% | +$166K | 0.06% | 263 |
|
|
2019
Q3 | $207K | Sell |
48,404
-2,696
| -5% | -$11.5K | 0.04% | 243 |
|
|
2019
Q2 | $298K | Sell |
51,100
-41,048
| -45% | -$239K | 0.06% | 217 |
|
|
2019
Q1 | $355K | Sell |
92,148
-10,740
| -10% | -$41.4K | 0.76% | 46 |
|
|
2018
Q4 | $192K | Sell |
102,888
-7,949
| -7% | -$14.8K | 0.03% | 178 |
|
|
2018
Q3 | $355K | Sell |
110,837
-79,225
| -42% | -$254K | 0.04% | 174 |
|
|
2018
Q2 | $574K | Buy |
190,062
+12,663
| +7% | +$38.2K | 0.51% | 134 |
|
|
2018
Q1 | $695K | Buy |
177,399
+95,675
| +117% | +$375K | 0.6% | 95 |
|
|
2017
Q4 | $338K | Buy |
81,724
+22,715
| +38% | +$93.9K | 0.42% | 105 |
|
|
2017
Q3 | $362K | Buy |
59,009
+5,397
| +10% | +$33.1K | 0.05% | 120 |
|
|
2017
Q2 | $333K | Buy |
53,612
+8,974
| +20% | +$55.7K | 0.05% | 95 |
|
|
2017
Q1 | $283K | Buy |
44,638
+4,279
| +11% | +$27.1K | 0.05% | 144 |
|
|
2016
Q4 | $216K | Buy |
40,359
+184
| +0.5% | +$985 | 0.06% | 170 |
|
|
2016
Q3 | $226K | Hold |
40,175
| – | – | 0.11% | 129 |
|
|
2016
Q2 | $221K | Buy |
40,175
+11,155
| +38% | +$61.4K | 0.16% | 125 |
|
|
2016
Q1 | $215K | Buy |
+29,020
| New | +$215K | 0.3% | 76 |
|